IBDEI0WW ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15433,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,15433,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,15434,0)
 ;;=F33.9^^58^663^13
 ;;^UTILITY(U,$J,358.3,15434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15434,1,3,0)
 ;;=3^MDD,Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,15434,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,15434,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,15435,0)
 ;;=F33.0^^58^663^10
 ;;^UTILITY(U,$J,358.3,15435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15435,1,3,0)
 ;;=3^MDD,Recurrent,Mild
 ;;^UTILITY(U,$J,358.3,15435,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,15435,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,15436,0)
 ;;=F33.1^^58^663^11
 ;;^UTILITY(U,$J,358.3,15436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15436,1,3,0)
 ;;=3^MDD,Recurrent,Moderate
 ;;^UTILITY(U,$J,358.3,15436,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,15436,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,15437,0)
 ;;=F33.2^^58^663^12
 ;;^UTILITY(U,$J,358.3,15437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15437,1,3,0)
 ;;=3^MDD,Recurrent,Severe
 ;;^UTILITY(U,$J,358.3,15437,1,4,0)
 ;;=4^F33.2
 ;;^UTILITY(U,$J,358.3,15437,2)
 ;;=^5003531
 ;;^UTILITY(U,$J,358.3,15438,0)
 ;;=F33.3^^58^663^7
 ;;^UTILITY(U,$J,358.3,15438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15438,1,3,0)
 ;;=3^MDD,Recurrent w/ Psychotic Features
 ;;^UTILITY(U,$J,358.3,15438,1,4,0)
 ;;=4^F33.3
 ;;^UTILITY(U,$J,358.3,15438,2)
 ;;=^5003532
 ;;^UTILITY(U,$J,358.3,15439,0)
 ;;=F33.41^^58^663^9
 ;;^UTILITY(U,$J,358.3,15439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15439,1,3,0)
 ;;=3^MDD,Recurrent,In Partial Remission
 ;;^UTILITY(U,$J,358.3,15439,1,4,0)
 ;;=4^F33.41
 ;;^UTILITY(U,$J,358.3,15439,2)
 ;;=^5003534
 ;;^UTILITY(U,$J,358.3,15440,0)
 ;;=F33.42^^58^663^8
 ;;^UTILITY(U,$J,358.3,15440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15440,1,3,0)
 ;;=3^MDD,Recurrent,In Full Remission
 ;;^UTILITY(U,$J,358.3,15440,1,4,0)
 ;;=4^F33.42
 ;;^UTILITY(U,$J,358.3,15440,2)
 ;;=^5003535
 ;;^UTILITY(U,$J,358.3,15441,0)
 ;;=F34.8^^58^663^6
 ;;^UTILITY(U,$J,358.3,15441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15441,1,3,0)
 ;;=3^Disruptive Mood Dysregulation Disorder
 ;;^UTILITY(U,$J,358.3,15441,1,4,0)
 ;;=4^F34.8
 ;;^UTILITY(U,$J,358.3,15441,2)
 ;;=^5003539
 ;;^UTILITY(U,$J,358.3,15442,0)
 ;;=F32.8^^58^663^1
 ;;^UTILITY(U,$J,358.3,15442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15442,1,3,0)
 ;;=3^Depressive Disorder NEC
 ;;^UTILITY(U,$J,358.3,15442,1,4,0)
 ;;=4^F32.8
 ;;^UTILITY(U,$J,358.3,15442,2)
 ;;=^5003527
 ;;^UTILITY(U,$J,358.3,15443,0)
 ;;=F34.1^^58^663^22
 ;;^UTILITY(U,$J,358.3,15443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15443,1,3,0)
 ;;=3^Persistent Depressive Disorder (Dysthymic)
 ;;^UTILITY(U,$J,358.3,15443,1,4,0)
 ;;=4^F34.1
 ;;^UTILITY(U,$J,358.3,15443,2)
 ;;=^331913
 ;;^UTILITY(U,$J,358.3,15444,0)
 ;;=F32.9^^58^663^5
 ;;^UTILITY(U,$J,358.3,15444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15444,1,3,0)
 ;;=3^Depressive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,15444,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,15444,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,15445,0)
 ;;=N94.3^^58^663^23
 ;;^UTILITY(U,$J,358.3,15445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15445,1,3,0)
 ;;=3^Premenstrual Dysphoric Disorder
 ;;^UTILITY(U,$J,358.3,15445,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,15445,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,15446,0)
 ;;=G31.84^^58^663^21
 ;;^UTILITY(U,$J,358.3,15446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15446,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,15446,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,15446,2)
 ;;=^5003813
